Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Walgreens Boots Alliance (NQ: WBA )

9.060 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Walgreens Boots Alliance

< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
69 70 Next >
Wire Buzzers: 3 Stocks Making Headlines You Can’t Ignore
Here are three stocks making headlines in the current market, offering attractive opportunities this Easter trading season. 
Via InvestorPlace
A Lifetime of Passive Income Is Hiding in Plain Sight
Real estate you visit frequently could supply you with a lifetime of passive income. 
Via The Motley Fool
7 Dividend Stocks to Secure Your Financial Freedom by 2026
Explore seven dividend stocks for financial freedom in banking, insurance, construction, pharmaceuticals, and telecommunications. 
Via InvestorPlace
7 Blue-Chip Stocks to Buy at a 52-Week Low in March
Investors looking for blue-chip stocks to buy for long-term growth in their portfolio should pick-up these stocks while they are on sale. 
Via InvestorPlace
The Dow’s Crown Jewels: 3 Stocks Poised for Unbeatable Returns
The DJIA has been the bellwether index for well over a century and these stocks poised for unbeatable returns. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
Walgreens Boots Alliance's Earnings: A Preview
Via Benzinga
Looking Ahead To Q1 Earnings
Via Talk Markets
Unpacking the Latest Options Trading Trends in Walgreens Boots Alliance
Via Benzinga
Why Walgreens Boots Alliance Stock Trounced the Market Today
The company notches convincing beats on headline fundamentals in its second-quarter earnings report. 
Via The Motley Fool
Stocks Pause As Traders Reassess Interest Rate Path, Gold Makes New Highs, Bitcoin Rebounds: What's Driving Markets Thursday?
In the final session of the short trading week leading up to Easter festivities, U.S. equity indices held steady, reflecting some setbacks in market expectations regarding interest rate reductions. 
Via Benzinga
Walgreens Is Paying A Hefty Cost For Its Healthcare Transformation But It's Not Giving Up Despite Scary Competition From Amazon
Like Amazon.com Inc (NASDAQ: AMZN), Walgreens Boots Alliance (NASDAQ: WBA) is going for its piece of the healthcare pie. 
Via Benzinga
Gold Gains 1%; Walgreens Narrows Earnings Forecast
U.S. stocks traded slightly higher midway through trading, with the S&P 500 gaining around 0.1% on Thursday. The Dow traded up 0.06% to 39,785.87 while the NASDAQ rose 0.06% to 16,408.04. The S&P 500... 
Via Benzinga
Topics Stocks
Exposures US Equities
WBA Stock Earnings: Walgreens Boots Alliance Beats EPS, Beats Revenue for Q2 2024
WBA stock results show that Walgreens Boots Alliance beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Walgreens Boots Alliance Shows Resilience In Q2 With $37.1B In Sales
Walgreens Boots Alliance demonstrated resilience and adaptability in its fiscal Q2, with a 6.3 percent increase in sales. 
Via Talk Markets
Walgreens Beats Estimates In Fiscal Q2
Walgreens Boots Alliance Inc. is trading slightly up in premarket on Thursday after reporting upbeat financial results for its second quarter. 
Via Talk Markets
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Walgreens Boots Alliance is starting to emerge from the weeds but has more work to do. The stock trades at rock bottom, a deep value, and pays a high yield. 
Via MarketBeat
Walgreens Boots Alliance Cuts Higher End Of 2024 Profit Outlook, Takes $5.8B Impairment Charge Related To VillageMD Business
Walgreens Boots Alliance's Q2 FY24 performance: Sales rise 6.3% to $37.1 billion, beating estimates. Adjusted EPS up 3.4% at $1.20. Notable growth in Pharmacy segment, despite retail challenges.... 
Via Benzinga
Wall Street Eyes Muted Open As Caution Prevails Before Key Inflation Data: Analyst Sees Buying Opportunities In Any Pullback
Following Wednesday’s late surge that pushed the S&P 500 Index to a record high, the market sentiment has shifted to cautious. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Walgreens Boots Alliance Reports Fiscal 2024 Second Quarter Results
From Walgreens Boots Alliance
Via Business Wire
RH, Walgreens And 3 Stocks To Watch Heading Into Thursday
With U.S. stock futures trading slightly lower this morning on Thursday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Investor Optimism Improves; S&P 500 Settles At New Record
The CNN Money Fear and Greed index showed some improvement in overall market sentiment on Wednesday, but it remained in the "Greed" zone. U.S. stocks closed higher on Wednesday, with the S&P 500... 
Via Benzinga
Topics Stocks
Exposures US Equities
Earnings Scheduled For March 28, 2024
Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million. 
Via Benzinga
Walgreens Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) is expected to release earnings results for its second quarter, before the opening bell on March 28, 2024. 
Via Benzinga
Participation Broadens As The Equal Weight S&P Rips, WBA Earnings
It’s getting harder and harder to make a bearish technical case against stocks. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Walgreens Challenges Nearly $1B Arbitration Award Over Alleged Breach of COVID-19 Test Business Contract
Walgreens Boots Alliance challenges a nearly $1 billion arbitration award issued to telemedicine provider PWNHealth, alleging excessive damages under contract terms. The dispute revolves around... 
Via Benzinga
Exposures COVID-19
What's Going On European Pharma Giant AstraZeneca Stock On Wednesday?
Japan approves AstraZeneca & Sanofi's Beyfortus for respiratory syncytial virus in neonates, infants, & children. Also, Truqap receives approval for unresectable or recurrent breast cancer. AstraZeneca... 
Via Benzinga
Supreme Court Signals Unlikelihood of Restricting Abortion Pill Access, Questions Legal Standing
The U.S. Supreme Court deliberates on abortion pill access amidst FDA regulations. Legal standing is scrutinized as justices weigh impacts on medical personnel and federal laws. This pivotal case... 
Via Benzinga
Exposures Product Safety
Abortion Back In Supreme Court Showdown In Election Year, Opponents Challenge Mifepristone Safety
Upcoming Supreme Court hearing on overturning Roe v. Wade, focusing on mifepristone access restrictions and FDA regulations. Learn about the pivotal implications for abortion rights and the broader... 
Via Benzinga
Exposures Product Safety
2 High-Yield Dividend Stocks Near 52-Week Lows. Time to Buy the Dips?
After a lousy year of declining prices, these stocks offer yields of 4.7% and 6.1% at recent prices. 
Via The Motley Fool
3 Dividend Aristocrat Stocks to Retire a Millionaire
These Dividend Aristocrat stocks can help you retire a millionaire by providing steady long-term compounding. 
Via InvestorPlace
< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
69 70 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.